透露潜在的药物点在精神分裂症通过蛋白质组范围的门德尔随机化遗传洞察力
Wenhuo Xie1, Jiaping Zheng2, Chenghua Kong1
1Department of Clinical Pharmacy and Pharmacy Administration, School of Pharmacy, Fujian Medical University, Fuzhou, China.
神经美丁B (NMB) 显示出作为精神分裂症 (SCZ) 的新疗法标的潜力. 增加的NMB水平与更高的SCZ风险和改变的大脑结构有关,这表明治疗开发的新途径.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 遗传学 遗传学 是一个
背景情况:
- 精神分裂症 (SCZ) 是一种严重的精神障碍,缺乏治愈方法.
- 识别新的药物点对于有效的SCZ治疗至关重要.
研究的目的:
- 使用孟德尔随机化 (MR) 调查蛋白质水平 (CSF和血) 与SCZ风险之间的关联.
- 探索已识别的蛋白质对与SCZ相关的大脑结构的影响.
主要方法:
- 进行了两个样本的门德尔随机化 (MR) 分析.
- 双向MR,斯泰格过和贝叶斯协同定位被用于验证.
- 研究了基因代理蛋白与大脑结构 (皮层SA,TH,皮下体积) 之间的关联.
主要成果:
- 在Bonferroni显著性时,确定了13种蛋白质-SCZ关联.
- 神经丁B (NMB) 蛋白水平与SCZ风险增加显著相关 (OR=1.41).
- 基因代理的NMB与副海马圈表面积 (SA) 有正相关,这与SCZ风险相反相关.
结论:
- 神经美丁B (NMB) 成为精神分裂症的有希望的药理学标.
- 对NMB的作用和成分进行进一步的研究是潜在的治疗开发的必要条件.
更多相关视频
07:35Methods for Studying the Mechanisms of Action of Antipsychotic Drugs in Caenorhabditis elegans
Published on: February 4, 2014
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
相关概念视频
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Antipsychotic Drugs: Typical and Atypical Agents
Psychosis and Antipsychotic Drugs: Overview
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
